North America Immunohistochemistry Market Research Report – Segmented By Product (Antibodies, Reagents, Equipment Kits), Application, End User & Country (The United States, Canada & Rest of North America) - Industry Analysis From 2025 to 2033

ID: 2737
Pages: 140

North America Immunohistochemistry Market Size

As per our report, the size of the North America Immunohistochemistry Market has been estimated at USD 660.26 million in 2025. It is further estimated to be growing at a CAGR of 7.6% and worth USD 1102.55 million by 2033.

The market is expected to show substantial growth during the forecast period as well as in the future years. Immunohistochemistry is a medical procedure that includes staining on a fresh or stored cancer tissue that is removed out during biopsy. This technique assists in the detection of hormone receptors on the surface of cancer cells. Immunohistochemistry is majorly used for the diagnosis of cancers, especially tumor antibodies.

The growth of technology in the biotech market and sudden commercialization are the major drivers for the growth of the market in this region.

The growth is hampered because of its requirement for extremely high capital and long R & D activities. But, the increasing adoption of immunohistochemistry products for the detection of tumors of unknown origin is leading to North America’s dominance.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2024 to 2033

Base Year

2024

Forecast Period

2025 to 2033

CAGR

7.6%

Segments Covered

By Product, Application, End User and Region.

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

U.S., Canada, Rest of North America

Market Leaders Profiled

F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Abcam plc, Cell Signaling Technology, Inc., and Bio SB Inc..

KEY MARKET PLAYERS

Key Participants dominating the North American Immunohistochemistry Market include

  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck Millipore
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Abcam plc
  • Cell Signaling Technology, Inc.
  • Bio SB Inc.

MARKET SEGMENTATION

This research report on North America Immunohistochemistry Market has been segmented and sub-segmented into the following categories.

By Product

  • Antibodies
  • Reagents
  • Equipment
  • Kits

By Application

  • Diagnostics
  • Drug Testing

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

By Country

  • The United States
  • Canada
  • Rest of North America

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample